Form 4: C3.ai Director Hyten Receives Stock Options
Insider Transaction Disclosure
C3.ai Director John E. Hyten was granted 28,628 stock options with an exercise price of $19.16, vesting quarterly over two years contingent on board meeting attendance.
Summary
- John E. Hyten, a Director at C3.ai, Inc. (AI), was granted 28,628 stock options.
- The options have an exercise price of $19.16 per share.
- The vesting commencement date for these options is October 3, 2025.
- Vesting occurs at 12.5% of the shares on the last day of each fiscal quarter for two years, provided the director attends regularly scheduled board meetings.
- If attendance requirements are not met, vesting for that quarter's shares is suspended but can vest after the second anniversary if subsequent attendance requirements are satisfied.
- The stock options are set to expire on October 2, 2035.
Sentiment
Score: 6
Explanation: Slightly positive, as the grant of stock options to a director is a standard practice that aligns their interests with long-term shareholder value and incentivizes continued engagement, reflecting a stable compensation strategy.
Positives
- Aligns the director's interests with long-term shareholder value through equity incentives.
- Incentivizes consistent board meeting attendance, promoting active governance and oversight.
Negatives
- Potential for future dilution if the options are exercised, which is a standard aspect of equity compensation.
Risks
- Vesting of the stock options is contingent on the reporting person remaining a director of the company and attending in person the regularly scheduled Board meetings during each fiscal quarter following October 3, 2025. Failure to attend will suspend vesting for that quarter's shares.
Future Outlook
The stock options are structured to vest over a two-year period, contingent on the director's continued service and active participation in board meetings, indicating a long-term incentive strategy for executive retention and performance alignment.
Industry Context
The granting of stock options to directors is a common practice in publicly traded companies, particularly within the technology sector, serving to align the interests of board members with those of shareholders and to incentivize long-term commitment and strategic oversight. The specific vesting conditions tied to board attendance represent a governance mechanism aimed at ensuring active participation.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Structure | Grant of stock options to Director John E. Hyten with vesting contingent on continued service and attendance at regularly scheduled board meetings. | 10/03/2025 | Enhances director alignment with shareholder interests and incentivizes active participation in corporate governance. |
Stakeholder Impact
- Shareholders: Potential long-term benefit from aligned director incentives; minor potential future dilution from option exercise.
- Director (John E. Hyten): Receives equity compensation, incentivizing continued service and performance.
Next Steps
- Continued service of John E. Hyten as a Director of C3.ai, Inc.
- Quarterly vesting of the stock options over the next two years, subject to the specified board meeting attendance requirements.
Key Dates
| Date | Description |
|---|---|
| 10/03/2025 | Vesting Commencement Date for the granted stock options. |
| 10/07/2025 | Date the Form 4 filing was submitted. |
| 10/02/2035 | Expiration Date of the stock options. |
Keywords
C3.ai, AI, Form 4, Insider Trading, Stock Options, Director Compensation, Equity Grant, John E. Hyten, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.